Farm Bill animal health funding jumps to $233 million

By Nathan Brooks

Annual federal funding for three USDA animal-health programs rises from $30 million to $233 million beginning in fiscal 2026, a $203 million increase aimed at disease detection, laboratory capacity and veterinary countermeasures.

On Nov. 6, 2026, USDA’s Animal and Plant Health Inspection Service said the increase for the National Animal Disease Preparedness and Response Program, National Animal Health Laboratory Network and National Animal Vaccine and Veterinary Countermeasures Bank comes through the 2025 Working Families Tax Cuts Act. APHIS says the money will let it modernize national preparedness, strengthen early detection and support faster responses to high-consequence animal diseases.

USDA Under Secretary Dudley Hoskins said the investment would “protect farmers’ and ranchers’ herds, their livelihoods and the rural communities they sustain.”

“Farm security is national security, and with this increased funding, we are strengthening early disease detection, expanding vaccine and diagnostic stockpiles and backing practical, on-the-ground projects that help producers prepare for and respond to the most serious animal disease threats,” Hoskins said.

Where is the $233 million going?

APHIS does not itemize the new $233 million among the three programs in its announcement, but it specifies several fiscal 2026 and fiscal 2027 funding streams.

For the National Animal Disease Preparedness and Response Program, or NADPRP, APHIS will make up to $80 million available through two competitive opportunities:

• The FY27 State Preparedness Funding Opportunity provides $40 million for state and regional capacity to prevent, prepare for, respond to and recover from foreign animal disease outbreaks. Eligible applicants include state departments of agriculture, state animal health officials and regional animal disease response organizations.
• The FY27 Industry Preparedness Funding Opportunity provides $40 million for producer and industry readiness through improved prevention, preparedness, response and recovery. Livestock producer organizations and veterinary organizations may apply.

Both opportunities open Nov. 5, 2026, and close Jan. 7, 2027. Selected projects should begin in spring 2027, according to APHIS.

The combined FY26-FY27 NADPRP plan also assigns $15 million to continue successful ongoing projects, $15 million for ad hoc preparedness needs and $20 million for APHIS-led work on critical response gaps. It also streamlines processes and aligns spending with priorities identified by stakeholders. Application instructions appear at www.aphis.usda.gov/funding/nadprp.

NADPRP funds federal, state, tribal and industry capacity against New World screwworm, highly pathogenic avian influenza, African swine fever and foot-and-mouth disease. Its emerging-threat work includes the Asian longhorned tick and Theileria orientalis Ikeda, a tick-transmitted parasite that causes severe, currently untreatable disease in cattle.

The program extends beyond laboratory work. APHIS says the projects also strengthen food security, producer resilience and the ability to detect outbreaks before they become more costly.

How do laboratory and vaccine capacity change?

The National Animal Health Laboratory Network, or NAHLN, coordinates federal, state and university-associated laboratories that test foreign and endemic high-consequence diseases. APHIS provided $10 million in noncompetitive FY26 funding and will award another $10 million in FY27 for operational support, personnel and rapid-response capacity.

The National Animal Vaccine and Veterinary Countermeasures Bank, or NAVVCB, stockpiles vaccines and other countermeasures for diseases such as foot-and-mouth disease. APHIS has invested more than $85 million in the bank since FY2020. For FY27, it plans more than $153 million in new investments for foot-and-mouth disease vaccine antigen concentrate, diagnostic test kits and other countermeasures.

APHIS describes the stockpile as insurance against a foot-and-mouth disease outbreak. It says the purchases should support a rapid response and faster recovery for farmers and ranchers. The announcement does not quantify available doses, outbreak probability or producer savings.

APHIS posts details on all three programs and its broader Farm Bill animal-health strategy at www.aphis.usda.gov/laws-regs/farm-bill.

What does this change for producers?

For producers, the immediate change is access to project funding and stronger public testing and response capacity, not a direct per-head payment. Individual farms are not named as eligible applicants, but livestock producer organizations can apply for the $40 million industry opportunity, allowing producers to participate through those groups.

For livestock margins, the relevant economic channel is lower disease loss and faster recovery, not a published change in feed, veterinary or other input costs. APHIS provides no livestock-price or basis forecast. The $233 million should not be treated as money entering farm balance sheets or evidence that margins will rise by a set amount.

The figures cover different reporting windows and award types. The $30 million and $233 million describe annual program funding beginning in FY26; $80 million covers two FY27 competitive opportunities; the $10 million FY26 NAHLN award is noncompetitive.

More than $153 million represents planned FY27 NAVVCB investments. These are budget and award figures, not survey estimates of disease prevalence or completed farm outcomes.

The next checkpoint is the selection process following the Jan. 7, 2027 close, with funded work expected to start in spring. Whether that spending improves laboratory throughput, fills vaccine gaps and limits producer losses will determine whether the larger funding increase becomes a practical farm benefit.